GHRH 5mg
$95.00
GHRH 5mg is the synthetic 44-amino-acid full-length native human growth-hormone-releasing hormone, the unmodified reference sequence distinct from the truncated Sermorelin and stabilised Tesamorelin analogs. Greater than 99 percent HPLC verified.
100 in stock
Buy GHRH 5mg – Peptide Science
GHRH 5mg Overview
GHRH 5mg from Peptide Science is the synthetic 44-amino-acid full-length native human growth-hormone-releasing hormone (also known as somatocrinin or somatoliberin), supplied as a lyophilised vial for in-vitro pituitary research. The compound is the unmodified native sequence, distinct from the stability-enhanced analogs Sermorelin (truncated 1-29) and Tesamorelin (44-residue with N-terminal trans-3-hexenoyl group).
Compound Class and Mechanism
GHRH 1-44 is the native hypothalamic peptide released from the arcuate nucleus that binds the GHRH receptor on pituitary somatotrophs and triggers growth-hormone synthesis and release through the adenylate cyclase / cAMP / PKA signalling cascade. The native unmodified form is short-acting in cell-culture conditions due to DPP-IV enzymatic cleavage at the position 2 to 3 peptide bond, which is the structural basis for the half-life-extending modifications in the Sermorelin (truncation) and Tesamorelin (trans-3-hexenoyl modification) analogs. Browse the broader growth-hormone peptide range.
Specifications
| Property | Value |
|---|---|
| Compound | GHRH (Growth Hormone-Releasing Hormone, native human 1-44 amide) |
| Class | Native human growth-hormone-releasing hormone; GHRH-receptor agonist reference compound |
| Amino-acid count | 44 |
| Molecular weight | approximately 5040 g/mol |
| Supplied form | Lyophilised powder, sealed vial |
| Strength | 5 mg per vial |
| Purity | greater than 99 percent (HPLC verified) |
| Storage | 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term |
For the truncated 29-residue Sermorelin format and the stabilised Tesamorelin format, see Sermorelin 5mg and Tesamorelin 5mg.
Reconstitution and Handling
The lyophilised vial reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. Aliquoting reconstituted stock for single-use frozen storage is the standard preclinical handling practice for short-sequence peptides.
Quality and Shipping
Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging.
For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws.


Reviews
There are no reviews yet.